Buckley C E, Buchman E, Falliers C J, Segal A T, Tinkelman D G, Wray B B, Butler V G, Wille L J, Tsai T H
Duke University Medical Center, Durham, NC 27710.
Ann Allergy. 1988 Feb;60(2):123-8.
A double-blind, parallel, multicenter study was undertaken in 215 ragweed skin test positive-patients with fall hay fever. The patients were randomized and treated for seven days with either 60 mg terfenadine twice daily, morning and evening, and a placebo at noon, or with 4 mg chlorpheniramine or placebo three times daily. The severity of nasopharyngeal itching, sneezing, rhinorrhea, nasal congestion, and itchy, watery, red eyes was ranked daily by patients and evaluated before and after treatment by the physician investigators. The patients reported a significant reduction in symptoms within one day. The physician investigators detected moderate to complete relief of symptoms in a greater proportion of the patients treated with terfenadine (70%) and chlorpheniramine (73%) than in the placebo-treated patients (48%). The incidence of sedation with terfenadine treatment (2.5%) was not different from that with placebo (2.4%) and both were lower than with chlorpheniramine (7.6%). We conclude that terfenadine is as effective as chlorpheniramine for the treatment of fall hay fever and that, unlike chlorpheniramine, the incidence of sedation with terfenadine was not different from placebo.
对215例秋季花粉症豚草皮肤试验呈阳性的患者进行了一项双盲、平行、多中心研究。患者被随机分组,接受为期七天的治疗,一组为每日早晚各服用60毫克特非那定,中午服用安慰剂;另一组为每日三次服用4毫克氯苯那敏或安慰剂。患者每天对鼻咽瘙痒、打喷嚏、流鼻涕、鼻塞以及眼睛瘙痒、流泪、发红的严重程度进行评分,医生研究人员在治疗前后进行评估。患者报告称症状在一天内显著减轻。与接受安慰剂治疗的患者(48%)相比,接受特非那定(70%)和氯苯那敏(73%)治疗的患者中,医生研究人员发现有更大比例的患者症状得到中度至完全缓解。特非那定治疗导致镇静的发生率(2.5%)与安慰剂(2.4%)无差异,且两者均低于氯苯那敏(7.6%)。我们得出结论,特非那定在治疗秋季花粉症方面与氯苯那敏一样有效,并且与氯苯那敏不同,特非那定导致镇静的发生率与安慰剂无差异。